Bacterial meningitis is a disease with high mortality and morbidity rates and with an estimated incidence between 1.4 and 2.6 per 100 000 adults [1] [2] [3] [4] . Streptococcus pneumoniae and Neisseria meningitidis are the most common causative pathogens of bacterial meningitis, causing 80% of all meningitis cases worldwide [5, 6] . In the past decade, dexamethasone therapy has successfully been implemented in the Netherlands as adjunctive treatment for pneumococcal and meningococcal meningitis in adults, resulting in an improved prognosis [7] [8] [9] [10] . However, concerns have been raised about the safety of dexamethasone in bacterial meningitis due to pathogens other than S. pneumoniae [6, 10, 11] . Guidelines recommend cessation of adjunctive dexamethasone if pathogens other than S. pneumoniae are cultured [6, 10, 11] .
Listeria monocytogenes is the third most frequent cause of bacterial meningitis, and is found in approximately 5% of cases [1] . Listeria monocytogenes meningitis occurs most frequently in elderly and immunocompromised patients, but incidentally occurs in healthy young adults, in whom disease mainly presents as brain-stem encephalitis [2, 3, 12] . There are 2 major L. monocytogenes genetic lineages, I and II, which differ in virulence characteristics [13] . Genetic diversity of L. monocytogenes strains can be determined by multilocus sequence typing (MLST) [14] .
We analyzed clinical characteristics, treatment, genetic diversity, and outcome of 92 adults with L. monocytogenes meningitis included in 2 prospective nationwide cohort studies. We compared characteristics of 30 episodes of listerial meningitis between 1998 and 2002 (before routine adjunctive dexamethasone therapy was introduced) to 62 cases between 2006 and 2012 [15] .
METHODS
We identified adults (>16 years of age) who had L. monocytogenes meningitis established by positive cerebrospinal fluid (CSF) culture and were listed in the database of the Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM) from March 2006 to April 2012. This laboratory receives CSF isolates from approximately 85% of all patients with bacterial meningitis in the Netherlands. Patients or their legal representatives received written information concerning the study and were asked to give written informed consent for participation. Patients with negative CSF cultures, hospital-acquired bacterial meningitis, or neurosurgical devices, and those within 1 month following neurosurgical procedure or neurotrauma, were excluded. The study was approved by the Medical Ethics Committee of the Academic Medical Center, University of Amsterdam, the Netherlands.
Patients with an altered immune status owing to splenectomy, diabetes mellitus, cancer, alcoholism, or the use of immunosuppressive drugs were considered immunocompromised, as were patients infected with human immunodeficiency virus. Mild hyponatremia was defined as a plasma sodium concentration <135 mmol/L and severe hyponatremia as <130 mmol/L [16] . Antibiotic treatment was categorized into 4 groups; monotherapy penicillin or amoxicillin, monotherapy third-generation cephalosporin, a combination of penicillin or amoxicillin and third-generation cephalosporin, and other regimens. Neurologic examination was performed at discharge, and outcome was scored according to the Glasgow Outcome Scale, with scores varying from 1 (death) to 5 (good recovery) [17] . A favorable outcome was defined as a score of 5, and an unfavorable outcome was defined as a score of 1-4. Clinical and laboratory characteristics, complications, treatment regimens, and outcome of included patients and microbiological characteristics of L. monocytogenes were compared to historical controls from a study with similar design that prospectively included 30 patients with L. monocytogenes meningitis from 1998 through 2002, before routine use of adjunctive dexamethasone was advised [15] . Data of both cohorts were combined to identify risk factors for an unfavorable outcome.
Lineage, serotype, and sequence type of cultured L. monocytogenes strains were determined of all available strains (n = 85) by the NRLBM. MLST was performed as described by Ragon and colleagues [13] . Seven different loci from the housekeeping genes of the bacterial genome (abcZ, bglA, cat, dapE, dat, ldh, and lhkA) were analyzed using polymerase chain reaction followed by automated sequencing [18] . Sequence types of the obtained data were determined and allocated according to the MLST database [14] .
The Mann-Whitney U test was used to identify differences between groups in continuous variables, and χ 2 or Fisher exact test were used to compare categorical outcomes. We used logistic regression to examine the association between potential predictors and the likelihood of an unfavorable outcome. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to quantify the strength of these associations. All statistical tests were 2-tailed, and P values of <.05 were considered to indicate statistical significance. All statistical analyses were performed with SPSS version 19.0. Lumbar puncture was performed in all patients, and only 46 (74%) had at least 1 CSF finding individually predictive for bacterial meningitis (CSF leukocyte count >2000 cells/mL, neutrophil count >1180 cells/mL, glucose level <1.9 mmol/L, protein level >2.2 g/L, or CSF-to-blood glucose ratio <0.23) [19] . CSF Gram staining was performed in 52 (84%) patients and was negative in 33 patients (63%). Demographics, clinical characteristics, and laboratory characteristics were similar between the 2006-2012 and 1998-2002 cohorts.
RESULTS

From
Initial antimicrobial treatment consisted of penicillin or amoxicillin in 11 patients (18%), third-generation cephalosporins in 12 patients (19%), and combination of penicillin or amoxicillin with a third-generation cephalosporin in 36 patients (58%; Table 2 ). In patients who did not receive penicillin or amoxicillin, treatment was switched to amoxicillin monotherapy or an amoxicillin-based antibiotic regimen after a median delay of 1 day (range, 1-4 days). Corticosteroids were administered in 41 patients (71%; Table 2 ). Four patients were treated with steroids for preexisting illness. Dexamethasone treatment was discontinued after L. monocytogenes was identified in only 2 of 41 patients (5%). In the 2006-2012 cohort, 33 (53%) patients received a standard regimen of dexamethasone (10 mg every 6 hours for 4 days, started with or before the first dose of antibiotics), compared to zero patients in the 1998-2002 cohort (0%; P = .001). In the 1998-2002 cohort, corticosteroids were administered in only 5 episodes (17%): 4 patients used prednisone or dexamethasone for preexisting conditions, and 1 patient was treated with dexamethasone after clinical deterioration. On admission, cranial computed tomography (CT) was abnormal in 13 of 50 patients (26%; remote infarctions in 4 patients, atrophy in 2, metastasis in 2, and brain edema, hydrocephalus, recent infarction, and arachnoid cyst in 1 patient each). Antimicrobial therapy was started before CT in only 20 of 50 patients (40%). During the clinical course, imaging was performed in 33 patients (CT in 29 patients, magnetic resonance imaging in 8 patients) and showed additional abnormalities in 18 (55%; hydrocephalus in 9, infarction in 5, brain edema in 2, and brain abscess and hemorrhage each in 1 patient; Table 3 ). Repeated lumbar puncture was performed in 12 of 62 patients (19%) after a median of 6.5 days (range, 2-32 days). Median CSF leukocyte count was 218 cells/μL (range, 23-1243 cells/μL), and 2 patients had persistent positive cultures for L. monocytogenes (1 of these patients initially received microbiologically inadequate antibiotic treatment).
Analysis of the 85 available L. monocytogenes strains from both cohorts showed that 56 strains belonged to L. serotypes was identified between the 2 cohorts, although serotype 4b tended to occur more often in the 2006-2012 cohort (P = .08). MLST analysis showed 26 unique sequence types. The most frequently identified genotypes were sequence type 6 (ST6) in 18 strains (21%), sequence type 2 in 13 strains (15%), and sequence type 1 in 11 (13%). There was emergence of L. monocytogenes ST6 over time: in the 2006-2012 cohort, 17 of the strains belonged to ST6 (29%), whereas only 1 strain in the 1998-2002 cohort belonged to ST6 (4%; P = .009). Occurrence of other sequence types was comparable between cohorts. Nine of 17 (53%) meningitis cases caused by ST6 L. monocytogenes occurred in 2010. However, we could not identify a specific outbreak as cases occurred throughout the year and were geographically spread through the country.
Unfavorable outcome occurred in 38 patients in the 2006-2012 cohort (61%), and 8 in the 1998-2002 cohort (27%; P = .002; Table 3 ). Mortality was also substantially higher in the 2006-2012 cohort (36% vs 17%, P = .06). The most common cause of death was multiorgan failure, which occurred in 8 of 22 patients (36%). Causes of death in other patients were (Table 5) . A multivariate analysis in the combined cohorts including immunocompromised state, advanced age, ST6, and adjunctive dexamethasone treatment showed that infection with a ST6 strain (OR, 3.77; 95% CI, 1.07-13.33) was associated with unfavorable outcome, whereas dexamethasone therapy, advanced age, and an immunocompromised state were not.
In an exploratory analysis, we compared clinical characteristics of patients infected by L. monocytogenes ST6 to those infected by other sequence types (Supplementary Table) . Infection with L. monocytogenes ST6 was associated with male sex (P = .007), lower CSF-to-blood glucose ratio (P = .02), higher body temperature (P = .04), and development of neurologic complications (P = .01), leading to an increased rate of unfavorable outcome (78% vs 45%, P = .02) and mortality (50% vs 25%, P = .045). Patients infected with other genotypes than ST6 showed a worse prognosis over time irrespective of emergence of ST6 infection (unfavorable outcome: 2006-2012 cohort, 55% vs 1998-2002, 28%; P = .03).
DISCUSSION
Our results show that L. monocytogenes meningitis is a severe disease that results in a high rate of unfavorable outcome (61%). We detected a 2-fold increase of the rate of unfavorable outcome in the period 2006-2012 as compared to 1998-2002, and considerable increase in the prevalence of 1 specific MLST listerial genotype, ST6, without clustering of cases suggestive of an outbreak. Genotype ST6 L. monocytogenes was the main determinant of unfavorable outcome in multivariate analysis (adjusted OR, 3.77).
Previous studies have reported low rates of ST6 L. monocytogenes among foodborne disease isolates. Italian and Chinese epidemiologic studies on sources of foodborne disease reported that <1% and <0.5%, respectively, of the L. monocytogenes isolates identified belonged to ST6 [20, 21] . Several epidemic clonal complexes (sequence types grouped by their similarity to a central allelic profile), with serotype 1/2a and serotype 4b as dominant serotype, have been described to be associated with bacterial virulence [22, 23] . However, these studies use a different MLST database [24] with other housekeeping genes, which makes it difficult to compare with the data we obtained and allocated according to the MLST database of the Pasteur Institute [14] . To our knowledge, we are the first to describe ST6 L. monocytogenes to be associated with disease outcome. Our data show that adjunctive dexamethasone is widely prescribed in patients with L. monocytogenes meningitis in the Netherlands. The drug was given to 71% of patients included between 2006 and 2012, and most patients received the recommended dose of 10 mg every 6 hours for 4 days started before or with the first dose of antibiotics. Dexamethasone therapy was not associated with unfavorable outcome in our cohort. Nevertheless, adjunctive dexamethasone treatment was another major change between cohorts, and as analysis in patients infected with other genotypes than 6 showed a worse prognosis over time irrespective of listerial ST6 infection, it seems reasonable to discontinue dexamethasone if L. monocytogenes is identified.
Inadequate initial treatment with cephalosporin monotherapy did not result in worse outcome. An explanation for this may be that the time to adjustment of antimicrobial therapy to an amoxicillin-based regimen was relatively short (median, 1 day). Another explanation may be that our study lacked power to detect a difference in outcome caused by inappropriate empiric antibiotic treatment.
Our study has limitations. First, only patients with a positive CSF culture for L. monocytogenes were included in this study. Negative CSF culture results occur in 11%-30% of patients with bacterial meningitis, and this percentage may be higher in patients with Listeria meningitis [1, 3, 25, 26] . Therefore, these patients are underrepresented in our cohort. Second, because a lumbar puncture in patients with space-occupying lesions on CT is usually not performed, these patients will be missed. This may explain the low rate of brain abscesses in our cohort as compared to the 5% in L. monocytogenes infections of the central nervous system reported in the literature [2] .
In conclusion, we detected a 2-fold increase of the rate of unfavorable outcome in the period 2006-2012 as compared with 1998-2002, caused by emergent L. monocytogenes genotype ST6. Because adjunctive dexamethasone is beneficial in the majority of bacterial meningitis patients, it should be initiated in all patients who present with suspected bacterial meningitis. However, as soon as L. monocytogenes is identified, dexamethasone may be discontinued as no beneficial effect had been found in Listeria meningitis.
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